Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
|
|
Axsome Therapeutics, Inc. (AXSM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2023 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 5,681 options to buy
@ $74.12, valued at
$421.1k
|
|
| 06/06/2023 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 5,681 options to buy
@ $74.12, valued at
$421.1k
|
|
| 06/06/2023 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 5,681 options to buy
@ $74.12, valued at
$421.1k
|
|
| 03/06/2023 |
4
| TABUTEAU HERRIOT (CEO) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 110,032 options to buy
@ $65.32, valued at
$7.2M
Granted 62,400 restricted stock units
@ $0 |
|
| 03/06/2023 |
4
| Jacobson Mark L. (COO) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 41,424 options to buy
@ $65.32, valued at
$2.7M
Granted 23,491 restricted stock units
@ $0 |
|
| 03/06/2023 |
4
| Pizzie Nick (CFO) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 36,246 options to buy
@ $65.32, valued at
$2.4M
Granted 20,554 restricted stock units
@ $0 |
|
| 03/06/2023 |
4
| Murdock Hunter R. (General Counsel) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 29,773 options to buy
@ $65.32, valued at
$1.9M
Granted 16,883 restricted stock units
@ $0 |
|
| 03/06/2023 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,870 options to buy
@ $65.32, valued at
$187.5k
|
|
| 03/06/2023 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,082 options to buy
@ $65.32, valued at
$136k
|
|
| 03/06/2023 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,224 options to buy
@ $65.32, valued at
$145.3k
|
|
| 01/04/2023 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Exercised 17,501 options to buy
@ $1.3, valued at
$22.8k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 16,976 options to buy
@ $25.53, valued at
$433.4k
|
|
| 03/17/2022 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Exercised 3,496 options to buy
@ $1.3, valued at
$4.5k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Jacobson Mark L. (COO) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 89,405 options to buy
@ $29.91, valued at
$2.7M
Granted 47,990 restricted stock units
@ $0 |
|
| 03/08/2022 |
4
| Pizzie Nick (CFO) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 77,872 options to buy
@ $29.91, valued at
$2.3M
Granted 41,176 restricted stock units
@ $0 |
|
| 03/08/2022 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,798 options to buy
@ $29.91, valued at
$83.7k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 3,950 shares
@ $37.3038, valued at
$147.4k
|
|
| 11/22/2021 |
4
| Pizzie Nick (CFO) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 527 shares
@ $35.5, valued at
$18.7k
Bought 141 shares
@ $35.43, valued at
$5k
Bought 145 shares
@ $34.3, valued at
$5k
Bought 142 shares
@ $35.2, valued at
$5k
|
|
| 11/22/2021 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 409 shares
@ $35.07, valued at
$14.3k
Bought 1,021 shares
@ $35.1, valued at
$35.8k
|
|
| 11/19/2021 |
4
| Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 3,000 shares
@ $34.5324, valued at
$103.6k
Bought 100 shares
@ $34.395, valued at
$3.4k
Bought 100 shares
@ $34.45, valued at
$3.4k
Bought 100 shares
@ $34.4, valued at
$3.4k
|
|
| 11/15/2021 |
4
| Pizzie Nick (CFO) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 36,086 options to buy
@ $39.26, valued at
$1.4M
|
|
| 11/15/2021 |
4
| Jacobson Mark L. (COO) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 41,638 options to buy
@ $39.26, valued at
$1.6M
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 7,325 options to buy
@ $61.32, valued at
$449.2k
|
|
| 05/13/2021 |
4
| Coleman Mark (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $58.15, valued at
$29.1k
|
|
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|